WASHINGTON TRUST Co bought a new stake in shares of Omega Healthcare Investors Inc (NYSE:OHI) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,685 shares of the real estate investment trust’s stock, valued at approximately $151,000.

Several other hedge funds have also recently modified their holdings of the business. First Trust Advisors LP increased its stake in shares of Omega Healthcare Investors by 139.6% during the fourth quarter. First Trust Advisors LP now owns 121,813 shares of the real estate investment trust’s stock valued at $5,159,000 after buying an additional 70,967 shares during the period. Trustcore Financial Services LLC lifted its position in shares of Omega Healthcare Investors by 48.3% in the 4th quarter. Trustcore Financial Services LLC now owns 40,969 shares of the real estate investment trust’s stock worth $1,735,000 after purchasing an additional 13,349 shares during the period. ARP Americas LP increased its holdings in Omega Healthcare Investors by 39.8% during the fourth quarter. ARP Americas LP now owns 33,032 shares of the real estate investment trust’s stock valued at $1,399,000 after buying an additional 9,400 shares during the period. Belpointe Asset Management LLC raised its stake in Omega Healthcare Investors by 22.3% in the fourth quarter. Belpointe Asset Management LLC now owns 4,347 shares of the real estate investment trust’s stock worth $184,000 after buying an additional 793 shares in the last quarter. Finally, Huntington National Bank purchased a new stake in Omega Healthcare Investors during the fourth quarter worth $27,000. Institutional investors and hedge funds own 74.45% of the company’s stock.

A number of equities research analysts recently weighed in on the company. Wells Fargo & Co decreased their price objective on Omega Healthcare Investors from $43.00 to $28.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Raymond James raised shares of Omega Healthcare Investors from an “outperform” rating to a “strong-buy” rating and increased their price target for the company from $32.00 to $34.00 in a research report on Friday. Zacks Investment Research upgraded shares of Omega Healthcare Investors from a “sell” rating to a “hold” rating in a report on Thursday, April 23rd. Citigroup reduced their price objective on shares of Omega Healthcare Investors from $44.00 to $25.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Finally, ValuEngine cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research report on Thursday, April 23rd. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Omega Healthcare Investors presently has a consensus rating of “Hold” and a consensus price target of $35.10.

In other news, Director Craig R. Callen bought 5,000 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The shares were purchased at an average price of $17.68 per share, for a total transaction of $88,400.00. Also, Director Craig R. Callen purchased 4,000 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The stock was acquired at an average price of $25.56 per share, for a total transaction of $102,240.00. Following the acquisition, the director now owns 32,000 shares in the company, valued at approximately $817,920. The disclosure for this purchase can be found here. Company insiders own 1.16% of the company’s stock.

Shares of Omega Healthcare Investors stock opened at $26.31 on Friday. The company has a 50 day moving average price of $28.42 and a 200 day moving average price of $37.53. The firm has a market capitalization of $6.06 billion, a P/E ratio of 16.14 and a beta of 0.90. The company has a quick ratio of 2.67, a current ratio of 3.93 and a debt-to-equity ratio of 1.31. Omega Healthcare Investors Inc has a 52 week low of $13.33 and a 52 week high of $45.22.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.39 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.03). Omega Healthcare Investors had a net margin of 37.71% and a return on equity of 8.66%. The company had revenue of $253.00 million for the quarter, compared to analyst estimates of $217.97 million. During the same quarter in the previous year, the company posted $0.76 EPS. The company’s revenue for the quarter was up 34.6% compared to the same quarter last year. As a group, research analysts anticipate that Omega Healthcare Investors Inc will post 2.92 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Thursday, April 30th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 10.19%. The ex-dividend date was Wednesday, April 29th. Omega Healthcare Investors’s payout ratio is 87.30%.

Omega Healthcare Investors Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Read More: Quiet Period

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.